Disrupt the Progression of Heart Failure | Abbott
CARDIOVASCULAR
hamburger
Hospitalized with Heart Failure

Up to 3 out of 4 people hospitalized with heart failure may die in 5 years.2


Your Actions are Critical

Recognizing subtle or overt signs that heart failure is advancing is critical to your patient’s long-term survival and quality of life. There are options to help you optimize medical therapy and in some cases offer solutions beyond medication.

Heart Failure Progression By the Numbers

Now is the time to act.

30% increased risk of mortality

Patients not on GDMT had nearly 30% increased risk of mortality.1

1% of HFrEF patients receiving optimal therapy

Only 1% of HFrEF patients are receiving optimal medical therapy.3

Up to 94% of heart failure patients risk death within 1 year

Up to 94% of Stage D heart failure patients only on GDMT may die within 1 year.4

Heart Failure Resources

Between Two Ventricles Podcast: Heart Failure Prevention, Is it possible?

A discussion between Drs. Kelly Axsom and Phil Adamson about how there needs to be a paradigm shift to use BNP as a marker to help catch patients sooner in their heart failure progression.

Podcast

The Impact of Health Care Disparities on Patients with Heart Failure

This paper highlights the known health care disparities that exist in the care of patients with HF and provides context for how clinicians and researchers should assess both biological and social determinants of HF risk in vulnerable populations, while providing a framework for future steps that can be used to help diminish inequalities in access and clinical outcomes over time, and offer solutions to help decrease disparities within HF care.

Impact of Health Care Disparities

Options Beyond Medical Therapy

Technology can help optimize heart failure medications and support your patients as their heart failure advances. Learn more about how each of these devices can help you and your patients.

Options Beyond Medical Therapy

Identifying heart failure progression

As heart failure progresses there are clinical events and triggers. Recognize the symptoms of advancing heart failure in your patients.

Identifying heart failure progression

Find a Heart Failure Center

Find a heart failure center for your patients so they can learn more about additional treatment options.

Connect with a Heart Failure Center
Enter city, state or zip code
Or use your location

Patient Education for Heart Failure

A resource to help patients learn more about heart failure and understand why they need to treat it with urgency.

Patient Education

Abbott does not endorse any of the clinics on this locator, but merely provides them as a courtesy to patients. Nor does Abbott represent that this is a full list of clinics in a particular location. The clinics are included in the locator because they provide implantable device support for Abbott devices; therefore, the directory is not meant to be an endorsement for any particular clinic. Note that Abbott is a medical device manufacturer and cannot provide medical advice.

References

  1. McCullough PA, Mehta HS, Barker CM, et al. Mortality and guideline-directed medical therapy in real-world heart failure patients with reduced ejection fraction. Clin Cardiol. 2021 Sep; 44(9): 1192–1198.
  2. Morris, A, Shah KS, Enciso JS, et al. The Impacts of Health Care Disparities on Patients with Heart Failure. J Card Fail. 2022 Jul;28(7):1169-1184.
  3. Greene SJ, Butler J, Albert NM. Medical Therapy for Heart Failure With Reduced Ejection Fraction. JACC 2018;72:351-366.
  4. Chaudhry S, DeVore Ad, Vidula H, et al. Left Ventricular Assist Devices: A Primer For the General Cardiologist. J Am Heart Assoc. 2022;11:e027251.
Find a Heart Failure Center

MAT-2302014 v1.0

DO YOU WISH TO CONTINUE AND EXIT CARDIOVASCULAR.ABBOTT?

CONTENTS OF THE SITE ARE NOT UNDER THE CONTROL OF ABBOTT.

False
accessibility
© 2021 Abbott. All Rights Reserved. Please read the Legal Notice for further details.

Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.

accessibility

DO YOU WISH TO CONTINUE AND EXIT CARDIOVASCULAR.ABBOTT?

CONTENTS OF THE SITE ARE NOT UNDER THE CONTROL OF ABBOTT.